Aug 26, 2024, 06:20
SBRT in Prostate Cancer at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn:
“Five-year outcomes from the hypo-FLAME trial, acute toxicity results from the PACE-C trial, and key findings from the STORM trial were revealed at ESTRO24. Learn how SBRT is advancing treatment and improving outcomes in prostate cancer.”
Read further.
Source: ESTRO/LinkedIn
More posts featuring ESTRO24 on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 14:33
Jan 15, 2025, 14:27
Jan 15, 2025, 14:23
Jan 15, 2025, 14:22
Jan 15, 2025, 14:19
Jan 15, 2025, 14:17
Jan 15, 2025, 14:15